Frank Boess

4.7k total citations · 1 hit paper
45 papers, 3.0k citations indexed

About

Frank Boess is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Frank Boess has authored 45 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 18 papers in Cellular and Molecular Neuroscience and 8 papers in Organic Chemistry. Recurrent topics in Frank Boess's work include Receptor Mechanisms and Signaling (12 papers), Neurotransmitter Receptor Influence on Behavior (12 papers) and Nicotinic Acetylcholine Receptors Study (11 papers). Frank Boess is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Neurotransmitter Receptor Influence on Behavior (12 papers) and Nicotinic Acetylcholine Receptors Study (11 papers). Frank Boess collaborates with scholars based in Switzerland, Germany and United Kingdom. Frank Boess's co-authors include Ian L. Martin, Viktor Lakics, Eric Karran, Andrew J. Sleight, Anne Bourson, Michael Bös, Rudy Schreiber, Jos Prickaerts, Rameen Beroukhim and F. Josef van der Staay and has published in prestigious journals such as Neurology, Annals of the New York Academy of Sciences and Journal of Neurochemistry.

In The Last Decade

Frank Boess

45 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular biology of 5-HT receptors

1994 568 citations Frank Boess, Ian L. Martin Neuropharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank Boess Switzerland	24	1.9k	1.4k	658	354	335	45	3.0k
Douglas W. Bonhaus United States	31	1.6k 0.9×	2.2k 1.6×	477 0.7×	622 1.8×	292 0.9×	78	3.6k
Xavier Langlois Belgium	38	2.1k 1.1×	2.3k 1.7×	435 0.7×	510 1.4×	212 0.6×	104	4.2k
Malcolm J. Sheardown Denmark	32	2.6k 1.4×	2.8k 2.0×	300 0.5×	414 1.2×	279 0.8×	82	4.1k
Eric S. Nisenbaum United States	32	1.5k 0.8×	2.4k 1.7×	309 0.5×	403 1.1×	117 0.3×	75	3.3k
Mark A. Varney United States	34	2.3k 1.2×	3.5k 2.5×	395 0.6×	614 1.7×	246 0.7×	85	4.6k
László G. Hársing Hungary	30	1.2k 0.6×	1.6k 1.2×	224 0.3×	311 0.9×	138 0.4×	138	2.7k
Ana Garcı́a-Osta Spain	31	1.9k 1.0×	794 0.6×	803 1.2×	989 2.8×	186 0.6×	59	3.4k
Lori L. McMahon United States	34	1.5k 0.8×	1.8k 1.3×	305 0.5×	481 1.4×	128 0.4×	80	3.4k
Michael P. Johnson United States	25	1.1k 0.6×	1.8k 1.3×	364 0.6×	260 0.7×	164 0.5×	52	2.6k
Ernesto Fedele Italy	36	1.5k 0.8×	1.5k 1.1×	587 0.9×	847 2.4×	95 0.3×	105	3.6k

Countries citing papers authored by Frank Boess

Since Specialization

Citations

This map shows the geographic impact of Frank Boess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Boess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Boess more than expected).

Fields of papers citing papers by Frank Boess

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Boess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Boess. The network helps show where Frank Boess may publish in the future.

Co-authorship network of co-authors of Frank Boess

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Boess. A scholar is included among the top collaborators of Frank Boess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Boess. Frank Boess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jankovic, Joseph, Ira Goodman, Beth Safirstein, et al.. (2018). Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease. JAMA Neurology. 75(10). 1206–1206. 224 indexed citations

Ziegler, Dan, Edith Schneider, Frank Boess, Lovisa Berggren, & Frank Birklein. (2014). Impact of comorbidities on pharmacotherapy of painful diabetic neuropathy in clinical practice. Journal of Diabetes and its Complications. 28(5). 698–704. 18 indexed citations

Buvat, Irène, Hartwig Büttner, Konstantinos Hatzimouratidis, et al.. (2013). Adherence to Initial PDE5 Inhibitor Treatment: Randomized OpenLabel Study Comparing Tadalafil Once a Day, Tadalafil on Demand, and Sildenafil on Demand in Patients with Erectile Dysfunction. The Journal of Sexual Medicine. 10(6). 1592–1602. 28 indexed citations

Happich, Michael, Edith Schneider, Frank Boess, et al.. (2013). Effectiveness of Duloxetine Compared With Pregabalin and Gabapentin in Diabetic Peripheral Neuropathic Pain. Clinical Journal of Pain. 30(10). 875–885. 29 indexed citations

Prickaerts, Jos, Nick P. van Goethem, Richard Chesworth, et al.. (2011). EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors. Neuropharmacology. 62(2). 1099–1110. 174 indexed citations

Blokland, Arjan & Frank Boess. (2008). Use of behavioural and long-term potentiation models in the development of memory-improving drugs. Expert Opinion on Drug Discovery. 3(9). 1067–1080. 3 indexed citations

Boess, Frank, Martin Hendrix, F. Josef van der Staay, et al.. (2004). Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance. Neuropharmacology. 47(7). 1081–1092. 251 indexed citations

Kampen, Marja van, et al.. (2004). AR-R 17779 improves social recognition in rats by activation of nicotinic α7 receptors. Psychopharmacology. 172(4). 375–383. 140 indexed citations

Steward, Lucinda J., et al.. (2000). Importance of Phenylalanine 107 in Agonist Recognition by the 5-Hydroxytryptamine3A Receptor. Molecular Pharmacology. 57(6). 1249–1255. 38 indexed citations

10.

Sleight, Andrew J., Frank Boess, Michael Bös, et al.. (1998). Characterization of Ro 04‐6790 and Ro 63‐0563: potent and selective antagonists at human and rat 5‐HT₆ receptors. British Journal of Pharmacology. 124(3). 556–562. 150 indexed citations

11.

Sleight, Andrew J., Frank Boess, Michael Bös, & Anne Bourson. (1998). The Putative 5‐ht₆ Receptor: Localization and Function. Annals of the New York Academy of Sciences. 861(1). 91–96. 34 indexed citations

12.

Boess, Frank, Frederick J. Monsma, & Andrew J. Sleight. (1998). Identification of Residues in Transmembrane Regions III and VI that Contribute to the Ligand Binding Site of the Serotonin 5‐HT₆ Receptor. Journal of Neurochemistry. 71(5). 2169–2177. 37 indexed citations

13.

Boess, Frank, et al.. (1998). The 5-Hydroxytryptamine6 Receptor-Selective radioligand [3H]Ro 63–0563 Labels 5-Hydroxytryptamine Receptor Binding Sites in Rat and Porcine Striatum. Molecular Pharmacology. 54(3). 577–583. 62 indexed citations

14.

Sleight, Andrew J., Frank Boess, Anne Bourson, David R. Sibley, & Frederick J. Monsma. (1997). 5-HT 6 and 5-HT 7 Receptors: Molecular Biology, Functional Correlates and Possible Therapeutic Indications.. Drug News & Perspectives. 10(4). 214–224. 12 indexed citations

15.

Boess, Frank, et al.. (1997). Analysis of the Ligand Binding Site of the 5-HT 3 Receptor Using Site Directed Mutagenesis: Importance of Glutamate 106. Neuropharmacology. 36(4-5). 637–647. 61 indexed citations

16.

Boess, Frank, et al.. (1997). Interaction of Tryptamine and Ergoline Compounds with Threonine 196 in the Ligand Binding Site of the 5-Hydroxytryptamine6 Receptor. Molecular Pharmacology. 52(3). 515–523. 29 indexed citations

17.

Bourson, Anne, et al.. (1997). Correlation between 5-HT7 receptor affinity and protection against sound-induced seizures in DBA/2J mice. Naunyn-Schmiedeberg s Archives of Pharmacology. 356(6). 820–826. 48 indexed citations

18.

Boess, Frank, et al.. (1997). Functional and Radioligand Binding Characterization of Rat 5-HT 6 Receptors Stably Expressed in HEK293 Cells. Neuropharmacology. 36(4-5). 713–720. 74 indexed citations

19.

Boess, Frank, Rameen Beroukhim, & Ian L. Martin. (1995). Ultrastructure of the 5‐Hydroxytryptamine₃ Receptor. Journal of Neurochemistry. 64(3). 1401–1405. 107 indexed citations

20.

Boess, Frank, Sarah C. R. Lummis, & Ian L. Martin. (1992). Molecular Properties of 5‐Hydroxytryptamine3 Receptor‐Type Binding Sites Purified from NG1O8‐15 Cells. Journal of Neurochemistry. 59(5). 1692–1701. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact